Hyundai plans to raise stake in China’s Sichuan Hyundai Motor
Category: #business  By Mateen Dalal  Date: 2019-10-22
  • share
  • Twitter
  • Facebook
  • LinkedIn

Hyundai plans to raise stake in China’s Sichuan Hyundai Motor

Hyundai Motor Company identifies the significance and impact of automobiles, and strives to fulfill its goals by creating new and advanced vehicles that addresses all the vital issues faced by drivers. The automobile giant has effectively become an international identity owing to its high-quality, groundbreaking products.

However, to further progress this development, Hyundai has recently revealed that it is planning to increase its stake in its floundering truck joint venture in China, dubbed Sichuan Hyundai Motor, evidentially joining other automakers that are increase their share in one of the world’s biggest car markets.

Reportedly, Sichuan Hyundai Motor is the automaker’s only commercial car venture in China that manufactures buses and cargo trucks. Both Hyundai and Sichuan Nanjun Automotive Group own 50% of stake in the joint venture firm.

However, in 2018, Beijing had eased its rules on foreign firms managing Chinese joint venture or automakers by eliminating caps on those manufacturers that make plug-in hybrid and fully electric vehicles. Additionally, caps on commercial vehicle manufacturer is expected to be relaxed by 2020, whereas the wider car market is expected to be eased in 2022.

Sources close to the development claim that Hyundai is reviewing several plans to reinforce the joint venture’s business in evolving Chinese market conditions. Meanwhile, German giant Volkswagen AG is hinting to buy a huge stake in Hyundai’s Chinese EV joint venture partner, with BMW agreeing to purchase control of the main Chinese joint venture.

For the record, the Sichuan joint venture commenced its operations in 2013 and has manufactured a total of 12,228 commercial vehicles until 2018, less than half from 28,786. This indicates that the Sichuan Hyundai’s production units are underutilized as it has the capacity of producing 10,000 buses and 160,000 trucks per year.

In addition to this, Hyundai Motor Group has also made some developments in the Chinese market when it announced plans to break into the region’s luxury car market with Genesis Motor in the coming years.

Source Credit: https://www.reuters.com/article/us-hyundai-motor-china/hyundai-motor-may-raise-stake-in-china-joint-venture-idUSKBN1X102L

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few o...

Read More

More News By Mateen Dalal

Arranta Bio acquires Captozyme to accelerate microbiome development
Arranta Bio acquires Captozyme to accelerate microbiome development
By Mateen Dalal

Arranta has established a Center of Excellence for microbiome development   The acquisition will help quicken the delivery of LBPs for clients worldwide Arranta Bio, a leading Contract Development Manufacturing Organization, recently annou...

CytoDyn obtains IRB approval for leronlimab for patients with TNBC
CytoDyn obtains IRB approval for leronlimab for patients with TNBC
By Mateen Dalal

Reports confirm that CytoDyn Inc., a late-stage biotechnology company has announced that it has recently received approval from the Institutional Review Board for leronlimab, to be directed to triple-negative breast cancer (TNBC) patients under a com...

FDA declines approval of Lipocine’s oral drug Tlando for third time
FDA declines approval of Lipocine’s oral drug Tlando for third time
By Mateen Dalal

FDA declines approval of Lipocine’s oral drug Tlando for third time Reportedly, the oral drug Tlando was first declined  approval by FDA in the year 2016. The U.S. Food and Drug Administration (FDA)  declined the approval of oral dr...